These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3320305)

  • 1. Prostaglandin E1: an effective treatment of right heart failure after orthotopic heart transplantation.
    Armitage JM; Hardesty RL; Griffith BP
    J Heart Transplant; 1987; 6(6):348-51. PubMed ID: 3320305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension.
    Murali S; Uretsky BF; Armitage JM; Tokarczyk TR; Betschart AR; Kormos RL; Stein KL; Reddy PS; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1992; 11(4 Pt 1):716-23. PubMed ID: 1498137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation.
    Vincent JL; Carlier E; Pinsky MR; Goldstein J; Naeije R; Lejeune P; Brimioulle S; Leclerc JL; Kahn RJ; Primo G
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):33-9. PubMed ID: 1728711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute right ventricular failure following heart transplantation: improvement with prostaglandin E1 and right ventricular assist.
    Fonger JD; Borkon AM; Baumgartner WA; Achuff SC; Augustine S; Reitz BA
    J Heart Transplant; 1986; 5(4):317-21. PubMed ID: 3305824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very high-dose prostaglandin E1 requirement for heart transplantation.
    Dorman BH; Harvey SC; Conroy JM; Crumbley AJ; Handy JR; Uber WE; Brahen NH
    J Heart Lung Transplant; 1992; 11(4 Pt 1):724-6. PubMed ID: 1498138
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
    Iberer F; Wasler A; Tscheliessnigg K; Petutschnigg B; Auer T; Müller H; Rödl S
    J Heart Lung Transplant; 1993; 12(2):173-8. PubMed ID: 8476887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement.
    D'Ambra MN; LaRaia PJ; Philbin DM; Watkins WD; Hilgenberg AD; Buckley MJ
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):567-72. PubMed ID: 4039017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
    Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 for treatment of elevated pulmonary vascular resistance in patients undergoing cardiac transplantation.
    Weiss CI; Park JV; Bolman RM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2555-6. PubMed ID: 2650332
    [No Abstract]   [Full Text] [Related]  

  • 12. Perioperative management of pulmonary hypertension after heart transplantation in childhood.
    Bauer J; Dapper F; Demirakça S; Knothe C; Thul J; Hagel KJ
    J Heart Lung Transplant; 1997 Dec; 16(12):1238-47. PubMed ID: 9436136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
    Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.
    Etz CD; Welp HA; Tjan TD; Hoffmeier A; Weigang E; Scheld HH; Schmid C
    Ann Thorac Surg; 2007 May; 83(5):1697-705. PubMed ID: 17462383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged amrinone therapy prior to orthotopic cardiac transplantation in patients with pulmonary hypertension.
    Bolling SF; Deeb GM; Crowley DC; Badellino MM; Bove EL
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):753-6. PubMed ID: 3279667
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.
    Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B
    Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.